CircCDYL2 stabilizes GRB7 by preventing its proteolytic ubiquitination and promoting its interaction with FAK in BC, which activates downstream PI3K/AKT and RAS/ERK signaling pathways to enhance trastuzumab resistance.315. This evidence concerns the gene AKT1 and breast cancer.